RHÖN-KLINIKUM Aktiengesellschaft (ETR:RHK)
Germany · Delayed Price · Currency is EUR 12.20
-0.70 (-5.43%)
May 8, 2026, 5:35 PM CET
ETR:RHK Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 1,726 | 1,705 | 1,596 | 1,464 | 1,446 | 1,402 |
Other Revenue | 277 | 266 | 272.24 | 270.75 | 215.07 | 189.2 |
| 2,003 | 1,971 | 1,868 | 1,735 | 1,661 | 1,591 | |
Revenue Growth (YoY) | 5.87% | 5.51% | 7.67% | 4.43% | 4.40% | 2.92% |
Cost of Revenue | 1,794 | 1,771 | 1,658 | 1,532 | 1,457 | 1,409 |
Gross Profit | 208.87 | 199.25 | 209.77 | 202.88 | 203.78 | 182.63 |
Selling, General & Admin | 4.1 | 4.1 | 4.9 | 4.8 | 4.3 | 3.8 |
Other Operating Expenses | 92.63 | 90.61 | 95.1 | 93.59 | 98.63 | 80.47 |
Operating Expenses | 157.08 | 154.92 | 162.62 | 163.88 | 172.47 | 154.91 |
Operating Income | 51.79 | 44.34 | 47.15 | 39 | 31.31 | 27.72 |
Interest Expense | -3.07 | -3.21 | -3.44 | -3.69 | -4.1 | -3.2 |
Interest & Investment Income | 7.24 | 7.24 | 11.07 | 10.52 | 1.3 | 0.5 |
Earnings From Equity Investments | 0.1 | 0.1 | 0.11 | 0.02 | 0.08 | 0.09 |
Other Non Operating Income (Expenses) | 1.06 | 1.6 | 1.2 | 2.18 | 2.04 | 1.2 |
EBT Excluding Unusual Items | 57.12 | 50.06 | 56.09 | 48.03 | 30.63 | 26.31 |
Impairment of Goodwill | -4.8 | -4.8 | - | - | - | - |
Gain (Loss) on Sale of Investments | -0.09 | -0.11 | 0.32 | - | - | -0.55 |
Gain (Loss) on Sale of Assets | -0.2 | -0.2 | -0.2 | -0.3 | -0.2 | -0.1 |
Other Unusual Items | - | - | - | - | 3.2 | 1.7 |
Pretax Income | 52.03 | 44.95 | 56.2 | 47.73 | 33.63 | 27.36 |
Income Tax Expense | 9.95 | 8.67 | 11 | 7.56 | 6.69 | -2.87 |
Earnings From Continuing Operations | 42.08 | 36.28 | 45.21 | 40.17 | 26.94 | 30.23 |
Minority Interest in Earnings | -2.03 | -1.81 | -1.86 | -1.46 | -1.8 | -1.93 |
Net Income | 40.05 | 34.47 | 43.35 | 38.71 | 25.14 | 28.3 |
Net Income to Common | 40.05 | 34.47 | 43.35 | 38.71 | 25.14 | 28.3 |
Net Income Growth | 0.92% | -20.48% | 11.98% | 53.96% | -11.14% | 1850.03% |
Shares Outstanding (Basic) | 67 | 67 | 67 | 67 | 67 | 67 |
Shares Outstanding (Diluted) | 67 | 67 | 67 | 67 | 67 | 67 |
Shares Change (YoY) | 1.77% | - | - | - | - | - |
EPS (Basic) | 0.59 | 0.51 | 0.65 | 0.58 | 0.38 | 0.42 |
EPS (Diluted) | 0.59 | 0.51 | 0.65 | 0.58 | 0.38 | 0.42 |
EPS Growth | -0.83% | -20.48% | 11.98% | 53.96% | -10.56% | 2000.00% |
Free Cash Flow | - | -41.9 | 57.2 | 46.2 | 2.1 | 19.7 |
Free Cash Flow Per Share | - | -0.63 | 0.85 | 0.69 | 0.03 | 0.29 |
Dividend Per Share | 0.200 | 0.200 | 0.100 | - | 0.150 | - |
Dividend Growth | 100.00% | 100.00% | - | - | - | - |
Gross Margin | 10.43% | 10.11% | 11.23% | 11.70% | 12.27% | 11.48% |
Operating Margin | 2.58% | 2.25% | 2.52% | 2.25% | 1.88% | 1.74% |
Profit Margin | 2.00% | 1.75% | 2.32% | 2.23% | 1.51% | 1.78% |
Free Cash Flow Margin | - | -2.13% | 3.06% | 2.66% | 0.13% | 1.24% |
EBITDA | 107.82 | 101.04 | 106.55 | 101.5 | 97.61 | 94.82 |
EBITDA Margin | 5.38% | 5.13% | 5.70% | 5.85% | 5.88% | 5.96% |
D&A For EBITDA | 56.03 | 56.7 | 59.4 | 62.5 | 66.3 | 67.1 |
EBIT | 51.79 | 44.34 | 47.15 | 39 | 31.31 | 27.72 |
EBIT Margin | 2.58% | 2.25% | 2.52% | 2.25% | 1.88% | 1.74% |
Effective Tax Rate | 19.12% | 19.28% | 19.57% | 15.84% | 19.89% | - |
Revenue as Reported | 2,005 | 1,972 | 1,869 | 1,736 | 1,666 | 1,600 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.